CIK 0001739104 · Large accelerated filer
Elanco Animal Health Inc
Sign in to watch- Ticker
- ELAN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 825497352
- Phone
- 877-352-6261
- Business address
- 450 ELANCO CIRCLE, INDIANAPOLIS, IN, 46221
- Open-market buys, last 90 days
- $1,030,193
- in 2 filings
- Open-market sales, last 90 days
- $100,050
- in 1 filing, $100K under 10b5-1 plans
Net +$930,143. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-30 | Kurzius Lawrence Erik Director | Grant or award | +18,649 | 52,916 | ||
| 2022-11-30 | Kurzius Lawrence Erik Director | Grant or award · Deferred Stock Units | +712.25 | $12.87 | $9K | 14,464.43 |
| 2022-11-30 | BILBREY JOHN P Director | Grant or award | +18,649 | 39,857 | ||
| 2022-11-30 | BILBREY JOHN P Director | Grant or award · Deferred Stock Units | +686.35 | $12.87 | $9K | 13,764.49 |
| 2022-11-11 | BILBREY JOHN P Director | Purchase | +7,500 | $13.24 | $99K | 41,722 |
| 2022-11-01 | de Brabander Ellen SEE REMARKS | Shares withheld for taxes | −11,295 | $13.28 | $150K | 48,836 |
| 2022-10-31 | BILBREY JOHN P Director | Grant or award · Deferred Stock Units | +669.7 | $13.19 | $9K | 13,078.14 |
| 2022-10-31 | HOOVER R DAVID Director | Grant or award · Deferred Stock Units | +808.69 | $13.19 | $11K | 25,118.78 |
| 2022-10-31 | Kurzius Lawrence Erik Director | Grant or award · Deferred Stock Units | +694.97 | $13.19 | $9K | 13,752.18 |
| 2022-09-30 | BILBREY JOHN P Director | Grant or award · Deferred Stock Units | +711.79 | $12.41 | $9K | 12,408.44 |
| 2022-09-30 | Kurzius Lawrence Erik Director | Grant or award · Deferred Stock Units | +738.65 | $12.41 | $9K | 13,057.21 |
| 2022-09-30 | HOOVER R DAVID Director | Grant or award · Deferred Stock Units | +859.52 | $12.41 | $11K | 24,310.09 |
| 2022-09-09 | HOOVER R DAVID Director | Purchase | +20,000 | $15.18 | $304K | 145,000 |
| 2022-03-02 | Meer James M CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −281 | $29.00 | $8K | 19,318 |
| 2022-03-01 | Meer James M CHIEF ACCOUNTING OFFICER | Grant or award | +2,955 | 19,982 | ||
| 2022-03-01 | Meer James M CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −383 | $28.94 | $11K | 19,599 |
| 2022-02-22 | Meer James M CHIEF ACCOUNTING OFFICER | Grant or award | +3,683 | 18,290 | ||
| 2022-02-22 | Meer James M CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −1,263 | $25.98 | $33K | 17,027 |
| 2022-01-03 | Meer James M CHIEF ACCOUNTING OFFICER | Grant or award | +3,540 | 14,607 |
Page 28 of 28 · 559 trades